Business

Washington Rejects AI Labs' Calls for Slower Development

Two frontier lab chief executives argued for pacing capability development. The President and the Speaker of the House said the race with China makes that unacceptable. The unusual thing about the AI slowdown debate that broke open over the…

Washington Rejects AI Labs' Calls for Slower Development
Washington Rejects AI Labs' Calls for Slower Development

Two frontier lab chief executives argued for pacing capability development. The President and the Speaker of the House said the race with China makes that unacceptable.

The unusual thing about the AI slowdown debate that broke open over the weekend is which side each participant is on. The companies building the most capable systems are arguing for restraint. The government that would ordinarily be asked to impose it is arguing against.

Anthropic chief executive Dario Amodei published an essay of roughly 3,800 words arguing that "we must slow the pace at which we improve the capabilities of A.I. models." OpenAI chief executive Sam Altman is reported to have agreed, saying "we need to pace the frontier" and describing pacing as a primary internal discussion topic at his company.

The position was not new to OpenAI's leadership. On , a week earlier, OpenAI chief scientist Jakub Pachocki published a post titled "An Alien Mind" arguing that no one is prepared for the consequences of a continued rapid rise in machine intelligence. He named specific risks, including AI agents breaching secure systems, pursuing independent objectives, and reasoning in ways humans cannot follow, and advocated voluntary slowdowns pending safety standards.

That is three of the most senior figures at the two leading American labs, on the record within a week, arguing for less speed.

The political response

President Trump argued against any mandated slowdown, saying the United States must preserve its technological lead, that negative forces were exaggerating the dangers, and that whoever wins AI, wins. He allowed that he was open to guardrails, without specifying any.

House Speaker Mike Johnson took a similar line, opposing a regulatory moratorium and warning that aggressive AI regulation would cause the United States to lose the race to China. He favored industry self-regulation over congressional action.

Neither proposed a specific policy. The response, so far, is a rejection rather than an alternative.

The unresolved part of the labs' own argument

Amodei has said China presents the "toughest dilemma" for his proposed slowdown, which is the same objection Washington raised, arriving from the opposite direction. A voluntary pace limit observed by American labs and ignored elsewhere produces a competitive transfer rather than a safety gain, and neither lab has described a mechanism that would prevent that.

That gap is what makes the proposal difficult to evaluate as policy rather than as principle. It is a call for restraint with no enforcement structure, addressed to a government that has now said it does not want to build one.

A claim circulating without a name attached to it

Alongside the essays, a further and considerably more alarming claim has been circulating. An Anthropic researcher's resignation is described as having included a warning that AI could kill us all by the end of the decade.

That claim should not be treated as established. No individual has been named, no resignation letter or statement supporting it has been made public, and neither Anthropic nor any identified employee has addressed it.

It is reproduced here because it is circulating widely enough that readers will encounter it, and because the distance between it and the essays above is the point. One is a named executive arguing a position under his own byline. The other is an anonymous secondhand warning, and until someone attaches a name to it, that is all it is.

Where it goes next

Self-regulation was the Speaker's preferred answer, and the labs have effectively proposed a version of it. The test of whether anything follows is not another essay. It is whether any company changes a product roadmap or a capital expenditure plan, and so far none has announced one.

More articles from FinancialMarkets.com